ERN/LRPT (Extended Release Niacin/Laropiprant)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ERN/LRPT (Extended Release Niacin/Laropiprant), covering 2012-02-17 to 2012-02-17. Get the full timeline:
Most recent: Clinical Trial Update: A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0524A-102) [Phase 3]